Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 3/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.61 |
| ▸ | TPMT | P51580 | 1/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA6 | P23280 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.55 |
| ▸ | KCNK9 | Q9NPC2 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29382709 | 1.00 | PARP1 (0.65) | PARP1POLBSMN1; SMN2HDAC8HDAC6 | |
| SCHEMBL14406 | 1.00 | PARP1 (0.65) | PARP1POLBSMN1; SMN2HDAC8HDAC6 | |
| Iodide SCHEMBL6113184 | 0.98 | PARP1 (0.63) | PARP1POLBSMN1; SMN2HDAC8HDAC6 | |
| SCHEMBL6915713 | 0.98 | PARP1 (0.63) | PARP1POLBSMN1; SMN2HDAC8HDAC6 | |
| SCHEMBL1151724 | 0.98 | PARP1 (0.63) | PARP1POLBSMN1; SMN2HDAC8HDAC6 | |
| SCHEMBL6910112 | 0.98 | PARP1 (0.63) | PARP1POLBSMN1; SMN2HDAC8HDAC6 | |
| SCHEMBL6916592 | 0.98 | PARP1 (0.63) | PARP1POLBSMN1; SMN2HDAC8HDAC6 | |
| SCHEMBL6917457 | 0.98 | PARP1 (0.63) | PARP1POLBSMN1; SMN2HDAC8HDAC6 | |
| Ammonia Solution, Strong SCHEMBL1667011 | 0.98 | PARP1 (0.63) | PARP1POLBSMN1; SMN2HDAC8HDAC6 | |
| Ammonia Solution, Strong SCHEMBL1667008 | 0.98 | PARP1 (0.63) | PARP1POLBSMN1; SMN2HDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120058024-A1 | SYSTEM AND PROCESS FOR PRODUCTION OF BENZOIC ACIDS AND PHTHALIC ACIDS | H R D CORPORATION (US) | 2012-03-08 | — | — | US | disclosed |
| US-7994330-B2 | Oxidizing p-xylene to terephthalic acid using a catalyst having a dicarboximide skeleton; hydrothermally treating the product with hot water, decomposing and removing catalyst impurities | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| WO-2011031424-A2 | HIGH SHEAR SYSTEM AND METHOD FOR THE PRODUCTION OF ACIDS | HRD CORPORATION (US) | 2011-03-17 | — | — | WO | disclosed |
| US-20110031000-A1 | RESIN COMPOSITION, CARRIER MATERIAL WITH RESIN, MULTI-LAYERED PRINTED CIRCUIT BOARD, AND SEMICONDUCTOR DEVICE | SUMITOMO BAKELITE CO., LTD. (JP) | 2011-02-10 | — | — | US | disclosed |
| US-20090092975-A1 | SELECTABLE MARKER | MOLOGIC LTD (GB) | 2009-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090092975-A1 | SELECTABLE MARKER | AMD1, PADI1, PSAT1 | PARP1 1276/4885POLB 425/4885SMN1; SMN2 3648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.